Repligen Corp (RGEN) Tops Q1 EPS by 3c; Boosts FY14 Revs Outlook
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $178.41 +0.12%
Revenue Growth %: +9.4%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.4%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.9 million.
Repligen Corp sees FY2014 revenue of $59 - $62 million, versus prior guidance of $58 - $61 million and the consensus of $59 million.
For earnings history and earnings-related data on Repligen Corp (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Restaurant Brands International (QSR) PT Raised to $86 at Guggenheim
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
